Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Leukemia, Myeloid, Acute 3Leukemia 3Stomach Neoplasms 2Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Vomiting 1Substance-Related Disorders 1Solid Tumors 1Recurrence 1Pituitary Neoplasms 1Pancreatic Neoplasms 1Opioid-Related Disorders 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Follicular 1Lymphoma 1Low Anterior Resection Syndrome 1Colonic Neoplasms 1Acromegaly 1

Interventions

Cisplatin 117Oxaliplatin 111Fluorouracil 100Capecitabine 90Docetaxel 69Leucovorin 60Irinotecan 57Paclitaxel 49S 1 (combination) 38pembrolizumab 35Trastuzumab 31Radiotherapy 25Bevacizumab 20Nivolumab 19Epirubicin 19titanium silicide 18Surgical Procedures, Operative 17Carboplatin 17Ramucirumab 16Cetuximab 15Gastrectomy 13apatinib 12Everolimus 12Gemcitabine 11Albumin-Bound Paclitaxel 10Neoadjuvant Therapy 8Folfox protocol 8Drug Therapy 8Chemotherapy, Adjuvant 8Radiation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Stomach Neoplasms × Dosage Forms × Clear all
NCT05410535 2024-06-28

To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy

Daewoong Pharmaceutical Co. LTD.

Phase 4 Completed
431 enrolled
Gastrointestinal

Stomach Neoplasms

NCT06250075 2024-05-13

PRONIC-G

Universidade Federal do Amazonas

Phase NA Completed
88 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡